Clinical Trial Update: Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of brimonidine eye drops for ocular graft-vs-host disease and dry eye has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Ocular Graft-versus-host Disease

Drugs mentioned

• Brimonidine eye drops (brimonidine tartrate)

Snippet

Sponsor: Sandeep Jain, MD | Conditions: Dry Eye, Ocular Graft vs Host Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2019-11-08